Here’s an updated 2013 look at protecting one’s own existing stem cells. Regenerative medicine is very exciting. But what’s even better than regenerative medicine? Preventative medicine. If one can prevent a problem from occurring in the first place, it is far better than trying to treat it after the fact. Of course in many cases […]
5 ways to protect your stem cells to stay healthy & younger Read More »
What the heck is going on with Intellicell Biosystems, Inc. (SVFC, also SVFCE), a stem cell corporation run by Dr. Steven Victor? Why are some on Wall Street seeming so bullish on the company lately? What’s the real story and the facts? What is the key background on this company? Wall Street has been buying
Wall Street Weirdness Over Stem Cell Biotech Intellicell (SVFC) Read More »
This is a guest post by Dr. Chris Centeno as I aim to bring in different viewpoints. By Christopher J. Centeno, M.D. We have noted an explosion in the number of stem cell clinics over the past several years. There’s not a day that goes by that I don’t see several new ones pop up on
Dr. Chris Centeno Guest Post on Risky Surge of Newbie Stem Cell Clinics Read More »
An interesting paper just came out in PNAS reporting the apparent presence of a pluripotent stem cell population in the adult breast. The paper is Roy, et al. and is from Thea Tlsty’s outstanding lab at UCSF. I have read the paper and it seems very solid technically to me. The finding has stimulated some
Caution on mammary pluripotent stem cell paper Read More »
There’s a new paper out this week in Cell from the Zaret lab that is very exciting. In this manuscript, Facilitators and Impediments of the Pluripotency Reprogramming Factors’ Initial Engagement with the Genome, Zaret’s team explores how Myc and Oct4, Sox2, and Klf4 (OSK) behave at the genomic level during cellular reprogramming. What are the most
Review of the new Zaret Cell paper on Myc & OSK in cellular reprogramming Read More »
The field of induced pluripotent stem cells (iPSC) has really shaken up science over the last half dozen years reversing our notion that differentiated cells are stuck in that fate, when in reality they are plastic and can “turn back the clock” to become embryonic stem cell-like cells. Now we have an iPSC paper in Nature,
Surprising human mosaicism means not all your cells have the same DNA Read More »
Pluristem Therapeutics Inc. is a publicly traded (NASDAQ) biotech Israeli company that is developing stem cell treatments based on the use of expanded placental stem cells called PLX cells. The Pluristem PLX drug is not approved for treating patients at this time in any country, however Pluristem has treated a handful of patients via something
Money and stem cell ‘miracles’: Pluristem questioned on ethics Read More »
A team from the Salk Institute in La Jolla led by Inder Verma has reported dedifferentiation in a paper in Science some important findings that I believe make their paper in the top 10 as a candidate for paper of the year. The paper, entitled “Dedifferentiation of Neurons and Astrocytes by Oncogenes Can Induce Gliomas
Dedifferentiation of neurons & astrocytes into glioma forming cells Read More »
It has been a big week in very different ways for the stem cell field related to induced pluripotent stem (iPS) cells. First, we had the Nobel Prize deservedly going to stem cell hero, Shinya Yamanaka. Great news! Congratulations to Dr. Yamanaka. Unfortunately, now, we have a puzzling story that iPS cells have been reported
Did Celltex just get an FDA warning letter? I’m not sure. We may find out tomorrow as the FDA updates their public warning letter list early in the week. What’s Celltex? Celltex is that famous stem cell company in Sugarland, Texas that gave Guv Rick Perry stem cell transplants. It was inspected by the FDA
Did Celltex just get an FDA warning letter? Read More »